iiinova — where your digital self keeps evolving

UCB @ucbglobal.bsky.social · 24/03/2026

We’re excited to share that we’ve selected Gwinnett County, Georgia for UCB’s new U.S. biologics manufacturing facility - a major milestone in our U.S. expansion and a long term commitment to patients, innovation & sustainable growth. For more: www.ucb.com/newsroom/pre...

010

UCB @ucbglobal.bsky.social · 26/02/2026

Strong execution. Sustained growth. Clear purpose. Our 2025 full-year results show how we’re turning scientific ambition into meaningful progress for people with severe diseases. We’re growing, innovating, and advancing our ESG priorities. 🔗 www.ucb.com/investors/ma...

012

UCB @ucbglobal.bsky.social · 14/01/2026

What a way to start our year: we’re on CDP’s Climate Change A List while keeping our A- for Water Security. This puts us in the top 4% of globally disclosing companies. 100% teamwork across our sites, thank you #TeamUCB! Learn more: www.ucb.com/about-ucb/su...

000

UCB @ucbglobal.bsky.social · 19/12/2025

And just like that, the festive season is here! ✨Thanks for being part of our journey here. For now, we’re swapping emails for greeting cards and deadlines for downtime! 💙 From all of us at #TeamUCB, season's greetings and our best wishes for 2026! 💙 #InspiredByPatients #DrivenByScience

000

UCB @ucbglobal.bsky.social · 08/12/2025

FOR MEDIA ONLY: UCB presents positive results from GEMZ phase 3 study in CDKL5 Deficiency Disorder www.ucb.com/newsroom/pre... #AES2025 #epilepsy

000

UCB @ucbglobal.bsky.social · 05/12/2025

FOR MEDIA ONLY: UCB showcases latest scientific research and advances in leading epilepsy portfolio at American Epilepsy Society Annual Meeting #AES2025 #epilepsy www.ucb.com/newsroom/pre...

000

UCB @ucbglobal.bsky.social · 29/10/2025

FOR MEDIA: Today is the first day of the American Association of Neuromuscular & Electrodiagnostic Medicine #AANEM 2025, and we are looking forward to presenting our new data on #MyastheniaGravis. Find out more about our latest research: www.ucb.com/newsroom/pre...

000

UCB @ucbglobal.bsky.social · 15/09/2025

#MitoAwarenessWeek highlights mitochondrial diseases like #TK2d. Delays in diagnosis due to limited knowledge & similarities with other myopathies can impact outcomes for the TK2d community. UCB is committed to increasing education for accurate diagnoses. More about TK2d: www.ucb.com/solutions/di...

010

UCB @ucbglobal.bsky.social · 09/09/2025

It's #TK2dTuesday! #TK2d affects 1.64 per 1 million globally, with varied onset and severity. UCB is committed to elevating understanding of the disease through collaboration with the community.

000

UCB @ucbglobal.bsky.social · 29/08/2025

FOR MEDIA: UCB presents latest research advancements across leading neurology portfolio at the International Epilepsy Congress, read more www.ucb.com/newsroom/pre... #IEC2025 #epilepsy

000

UCB @ucbglobal.bsky.social · 04/08/2025

Growth is one thing. Doing it responsibly is another. We’re doing both. 🌱 🔗 Learn more: www.ucb.com/investors/pe... #TeamUCB #Sustainability

The image reads: We’re growing responsibly. We’re advancing our
environmental and social commitments, strengthening transparency across our value chain.

110

UCB @ucbglobal.bsky.social · 31/07/2025

📈 #UCBusinessUpdate At the half-year mark, we’re proud of #TeamUCB’s progress, as we’re driving sustainable growth and delivering for people living with severe diseases. For more, visit ucb.com: www.ucb.com/investors/ma... #InspiredByPatients #DrivenByScience

010

UCB @ucbglobal.bsky.social · 08/07/2025

FOR MEDIA: UCB presents the latest research advancements at the European Pediatric Neurology Society Congress, read more www.ucb.com/newsroom/pre... #EPNS

000

UCB @ucbglobal.bsky.social · 01/07/2025

Proud to be named one of TIME & Statista’s World’s Most Sustainable Companies 2025! #129 globally, #2 in BE. Another milestone in our journey to responsible, ethical innovation. #Sustainability

100

UCB @ucbglobal.bsky.social · 25/06/2025

UCB is dedicated to raising awareness of #MyastheniaGravis and its impact. Anna Kole emphasizes that elevating the community’s voice via initiatives like #FacesofMG can help identify how to support those living with MG and help improve standards of care. #MGAwarenessMonth

000

UCB @ucbglobal.bsky.social · 24/06/2025

Unveiling new insights at this year’s European Academy of Neurology (#EAN) Congress. We're focused on improving life for those with #MyastheniaGravis & #Epilepsy. Together, let's make a difference! Learn more: www.ucb.com/solutions/di...

000

UCB @ucbglobal.bsky.social · 24/06/2025

Developmental and epileptic encephalopathies (DEEs) don’t just affect children. At 17, Mia is living with Dravet syndrome (DS), facing the difficult transition to adult care. Learn more about DS here: www.ucb.com/solutions/di... #DravetAwareness #MoreThanSeizures

000

UCB @ucbglobal.bsky.social · 23/06/2025

On #DravetAwarenessDay, we remember Dr Charlotte Dravet, the pediatric epilepsy specialist who first described Dravet syndrome and was a leading advocate for improved care for children with epilepsy. Thank you, Charlotte

010

UCB @ucbglobal.bsky.social · 23/06/2025

On #DravetAwarenessDay UCB’s Andrea Wilkinson explains why Dravet syndrome and other developmental and epileptic encephalopathies are about #MoreThanSeizures and impact all aspects of daily life for patients and their families. Find out more here www.ucb.com/innovation/m...

000

UCB @ucbglobal.bsky.social · 17/06/2025

CDD is about #MoreThanSeizures, it’s about daily challenges and interruptions to family life, it’s about skipping lunch to provide care. On World #CDKL5 Day, hear from Karen Utley, President & Co-Founder, International Foundation for CDKL5 Research, about her experiences. #CDKL5awareness

010

UCB @ucbglobal.bsky.social · 11/06/2025

#MyastheniaGravis (MG) deeply affects daily life, with fluctuating, often invisible symptoms that make diagnosis uniquely challenging. At UCB, we’re committed to working with the #MG community to address care gaps. #MGAwarenessMonth. Learn more about myasthenia gravis here: bit.ly/4j5NIT1

000

UCB @ucbglobal.bsky.social · 10/06/2025

To mark #MGAwarenessMonth, we're highlighting the importance of understanding #MyastheniaGravis (MG), a widely misunderstood rare condition. UCB aims to create solutions to tackle the challenges faced by those living with #MG. Discover more about MG here: bit.ly/4j5NIT1

010

UCB @ucbglobal.bsky.social · 14/05/2025

At this year’s Myasthenia Gravis Foundation of America's (#MGFA) International Conference, we look forward to sharing our latest data in #MG. We aim to contribute valuable insights that can lead to better understanding and management of MG. Learn more here: bit.ly/4j5NIT1

000

UCB @ucbglobal.bsky.social · 13/05/2025

FOR MEDIA: UCB presents expansive data set at 15th Myasthenia Gravis Foundation of America (MGFA) International Conference, read more www.ucb.com/newsroom/pre... #MGFA #MyastheniaGravis #MG

000

UCB @ucbglobal.bsky.social · 13/05/2025

We’re thrilled to attend the year’s Myasthenia Gravis Foundation of America's (#MGFA) International Conference, where we’ll share 21 presentations across our targeted portfolio in #MG. Will you be part of the conversation? Learn more here: bit.ly/4j5NIT1

000